Nancy Chung-Welch - 09 Sep 2025 Form 4 Insider Report for Predictive Oncology Inc. (POAI)

Reporting relationship: Director
Issuer ticker: POAI
Reported as of: 09 Sep 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Sep 2025, 17:46:18 UTC
Prior SEC filing: 12 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/Josh Blacher, Attorney-in-Fact

Key filing fact

Nancy Chung-Welch filed Form 4 for Predictive Oncology Inc. (POAI) on 11 Sep 2025.

Key facts

This page summarizes Nancy Chung-Welch's Form 4 filing for Predictive Oncology Inc. (POAI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Sep 2025, 17:46.

Change

Previous filing in this sequence was filed on 12 Apr 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001817690 Primary reporting owner

CHUNG-WELCH NANCY

Relationship: Director
Address: C/O PREDICTIVE ONCOLOGY INC., 91 43RD STREET SUITE 110, PITTSBURGH
Signature: /s/Josh Blacher, Attorney-in-Fact
Signature date: 11 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

POAI transaction

Common Stock

Award

Transaction value: $0
Shares: +64,680
Change %: +335%
Price: $0.000000
Shares after: 83,993
Date: 09 Sep 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The grant consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs shall vest in full on October 31, 2025, subject to continued service through the applicable vesting date.